Cambrex Karlskoga AB is a pharmaceutical company that operates as a global contract development and manufacturing organization (CDMO). The company specializes in providing a range of services related to drug substance and drug product development. Cambrex Karlskoga offers comprehensive analytical services, which are essential for ensuring the quality and efficacy of pharmaceutical products.
The company has a strong focus on custom active pharmaceutical ingredient (API) development and manufacturing, with expertise in generic API manufacturing and peptide development. Cambrex Karlskoga also provides capabilities for API technology transfer, allowing for the seamless transition of processes from development to commercial production. Additionally, the organization offers specialty solutions tailored to meet specific client needs, including reactor build and design services.
To support drug development, Cambrex Karlskoga provides Investigational New Drug (IND) enabling services, which are crucial for advancing new therapies through regulatory processes. The extensive analytical testing services offered by the company further ensure quality assurance throughout the development and manufacturing stages.
